Literature DB >> 17616437

Are peroxiredoxins tumor suppressors?

Carola Anke Neumann1, Quan Fang.   

Abstract

It has been known for many years that free radicals, such as reactive oxygen species (ROS) and reactive nitrogen species (RNS), promote diseases such as cancer. Peroxiredoxins (Prdxs) are small H(2)O(2) scavenging proteins that appear to have tumor preventive functions since loss of Prdx1 in mice leads to premature death from cancer. However, as Prdxs are antioxidants they also scavenge the H(2)O(2) in cancer cells that way supporting survival and tumor maintenance. This suggests that Prdxs function as tumor 'preventers' rather than as tumor suppressors since they do not induce cell death when re-expressed in cancer cells, as it occurs with the tumor suppressor p53. Therefore, the knowledge of Prdx function and regulation may help provide a fuller understanding of the role of ROS in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616437     DOI: 10.1016/j.coph.2007.04.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  47 in total

Review 1.  Overview of peroxiredoxins in oxidant defense and redox regulation.

Authors:  Leslie B Poole; Andrea Hall; Kimberly J Nelson
Journal:  Curr Protoc Toxicol       Date:  2011-08

2.  Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer.

Authors:  Bo Zhang; Kai Wang; Gang He; Xinying Guan; Botao Liu; Yangbo Liu; Yun Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

Review 3.  The Multifaceted Impact of Peroxiredoxins on Aging and Disease.

Authors:  Svetlana N Radyuk; William C Orr
Journal:  Antioxid Redox Signal       Date:  2018-01-17       Impact factor: 8.401

4.  ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-Lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Tumour Biol       Date:  2012-10-13

5.  Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.

Authors:  Jie Zhou; Weiwen Shen; Xiaojing He; Jing Qian; Shiyuan Liu; Guanzhen Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: Nalpha-terminal acetylation of human peroxiredoxin II.

Authors:  Jae Ho Seo; Jung Chae Lim; Duck-Yeon Lee; Kyung Seok Kim; Grzegorz Piszczek; Hyung Wook Nam; Yu Sam Kim; Taeho Ahn; Chul-Ho Yun; Kanghwa Kim; P Boon Chock; Ho Zoon Chae
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

7.  Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer.

Authors:  B Turner-Ivey; Y Manevich; J Schulte; E Kistner-Griffin; A Jezierska-Drutel; Y Liu; C A Neumann
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

8.  Regulation of reactive oxygen species homeostasis by peroxiredoxins and c-Myc.

Authors:  J Anthony Graves; Mallikarjuna Metukuri; Donald Scott; Kristi Rothermund; Edward V Prochownik
Journal:  J Biol Chem       Date:  2008-12-19       Impact factor: 5.157

9.  Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell.

Authors:  Da-Jian Zhu; Xiao-Wu Chen; Jia-Zhi Wang; Yong-Le Ju; Man-Zhao Ou Yang; Wei-Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

10.  Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.

Authors:  Juxiang Cao; Jennifer Schulte; Alexander Knight; Nicholas R Leslie; Agnieszka Zagozdzon; Roderick Bronson; Yefim Manevich; Craig Beeson; Carola A Neumann
Journal:  EMBO J       Date:  2009-04-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.